In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
review
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
This paper explores the relationship between in vitro dissolution testing and in vivo drug absorption for lipophilic, poorly water-soluble compounds.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Although several routes of administration can be considered for new drug entities, the most popular remains the oral route. To predict the in vivo performance of a drug after oral administration from in vivo data, it is essential that the limiting factor to absorption can be modelled in vitro. In the case of BCS class II drugs dissolution is rate-limiting to absorption, so the use of biorelevant dissolution tests can be used to predict differences in bioavailability among different formulations and dosing conditions. To achieve an a priori correlation, the composition, volume and hydrodynamics of the contents in the gastrointestinal lumen following administration of the dosage form must be accurately simulated. Four media have been chosen/developed to model composition of the gastric and intestinal contents before and after meal intake. These are SGF, milk, FASSIF and FeSSIF, which model fasted and fed state conditions in the stomach and small intestine respectively. Using these media, excellent correlations have been obtained with the following poorly soluble drugs: danazol, ketoconazole, atovaquone and troglitazone. In all cases, fed vs. fasted state effects can be predicted from dissolution data and, where several formulations were available for testing, dissolution tests could also be used to determine which would have the best in vivo performance.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (16)
- Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles via openalex
- doi:10.1023/a:1011910801212 via openalex
- doi:10.1001/jama.1908.25310270030002f via openalex
- doi:10.1023/a:1018959511323 via openalex
- doi:10.1002/jps.2600570809 via openalex
- doi:10.1016/0378-5173(87)90239-0 via openalex
- doi:10.1093/jac/6.4.552 via openalex
- doi:10.1002/jps.2600750202 via openalex
- doi:10.1128/aac.25.1.1 via openalex
- W6652293330 via openalex
- doi:10.1023/a:1011071401306 via openalex
- doi:10.1023/a:1016212804288 via openalex
- doi:10.3109/15563657708989827 via openalex
- doi:10.1056/nejm191002241620814 via openalex
- doi:10.1007/bf02233563 via openalex
- doi:10.1023/a:1018907527253 via openalex
Cited by (5)
- The in vivo predictive dissolution for immediate release dosage of donepezil and danazol, BCS class IIc drugs, with the GIS and the USP II with biphasic dissolution apparatus 2019
- Danazol 2007
- Supersaturation Produces High Bioavailability of Amorphous Danazol Particles Formed by Evaporative Precipitation into Aqueous Solution and Spray Freezing into Liquid Technologies 2006
- Rapid release tablet formulation of micronized danazol powder produced by spray-freezing into liquid (SFL) 2004
- A dynamic in vitro lipolysis model 2001
Source provenance
- openalex
- last seen: 2026-05-11T06:03:29.626429+00:00
License: CC0
· commercial use OK